TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
IPSC

Century Therapeutics Inc

Healthcare · Biotechnology

1.60$ -5.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement IPSC
Line item 2015 2016 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% – – 100.0% 100.0% 100.0% 100.0% 100.0%
93.5% 99.5% – – 433.1% 193.7% 583.6% 201.9% 12.0%
6.5% 0.5% – – -433.1% 100.0% 100.0% 100.0% 88.0%
1.2% 1.9% – – 7,150.1% 1,869.1% 4,148.1% 1,627.6% 87.6%
11.4% 17.3% – – 1,818.1% 612.8% 1,552.8% 503.2% 22.0%
– – – – 8,535.1% 2,674.2% 6,656.9% 2,196.5% 101.8%
– – – – -8,968.1% -2,574.2% -6,556.9% -2,096.5% -13.8%
0.0% 0.0% – – 120.5% 21.3% 24.2% 0.0% –
– – – – -9,053.0% -2,516.7% -6,031.0% -1,893.7% -8.8%
– – – – 4.1% 1.8% 84.2% 27.2% -0.1%
– – – – -9,057.1% -2,518.4% -6,115.1% -1,920.9% -8.8%
– – – – -8,499.4% -2,331.2% -5,423.2% -1,691.8% 3.2%

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?